Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 257-856-5 | CAS number: 52334-81-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vivo
Administrative data
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
- Remarks:
- Type of genotoxicity: chromosome aberration
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- Experimental phase: 7 - 29 April 1983.
- Reliability:
- 1 (reliable without restriction)
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 984
- Report date:
- 1984
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 474 (Mammalian Erythrocyte Micronucleus Test)
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- micronucleus assay
Test material
- Reference substance name:
- 2-chloro-5-(trifluoromethyl)pyridine
- EC Number:
- 257-856-5
- EC Name:
- 2-chloro-5-(trifluoromethyl)pyridine
- Cas Number:
- 52334-81-3
- Molecular formula:
- C6H3ClF3N
- IUPAC Name:
- 2-chloro-5-(trifluoromethyl)pyridine
- Details on test material:
- CTF, 2-chloro-5-(trifluoromethyl)pyridine. CTL No. Y02424/003/001, is a white solid with a melting point of 32°C, a boiling point of 152°C, and a stated purity of <98%. CTF was supplied by Mond Division, Imperial Chemical Industries PLC, Runcorn Heath, Cheshire, UK.
Constituent 1
Test animals
- Species:
- mouse
- Strain:
- C57BL
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- Male and femal C57BL/6J mice (6-8 weeks old) were used for both phase I and Phase II of the study. The animals were supplied by the Animal Breeding Unit, Alderley Park, Macclesfield, Cheshire.
On arival the mice were housed ten per cage on mobile mouse racks and given food (Porton Combined Diet (PCD) supplied by Special Diets Services Ltd, Stepfield, Witham, Essex, UK) and filtered tap water (via an automated watering system) ad libitum.
The temperature of the animal cell was maintained in the range 20-26°C and a relative humidity range of 36-65%. Temperature and relative humidity were measured on a maximum and minimum thermometer and hygrometer respectively, and were recorded in the CTL Cleanside Temperature Record Book. Lighting was cycled with 12 hours light and dark each 24 hours. The animal cell was under negative pressure with respect to the access corridor and had approximately 22 air changes per hour.
Administration / exposure
- Route of administration:
- intraperitoneal
- Vehicle:
- Kraft Wesson Corn oil, supplied by Kraft Foods Ltd, Liverpool UK.
- Details on exposure:
- Dosing of the animals for the micronucleus test:
Animals were given a single dose, using doses equivalent to 80% or 50% of the LD50/7day by intraperitoneal injection. The lower dose level was used to ensure a test result in the event of deaths in the top dose and to allow the observation of a dose response, should the higher dose give a positive result. - Duration of treatment / exposure:
- Single ip injection
- Frequency of treatment:
- once
- Post exposure period:
- 24, 48 and 72 hours
Doses / concentrationsopen allclose all
- Remarks:
- Doses / Concentrations:
600 mg/kg i.p.
Basis:
other: based on 80% of i.p. LD50 (7day)
- Remarks:
- Doses / Concentrations:
375 mg/kg i.p.
Basis:
other: based on 50% i.p. LD50 (7 day)
- No. of animals per sex per dose:
- 5 M and 5F (at the sampling times 24, 48 and 72 hours)
- Control animals:
- yes, concurrent vehicle
- Positive control(s):
- Cyclophosphamide
65 mg/kg i.p. in physiological saline
5M and 5F (at the sampling times 24, 48 and 72 hours)
Examinations
- Tissues and cell types examined:
- Bone marrow from the femur
- Details of tissue and slide preparation:
- a) Femurs were removed and stripped of muscle
b) The iliac end of the femur was removed, and a fine paint brush wetted with a solutionn of albumen (6% w/v in saline) was dipped into the marrow canal.
c) 3 to 4 streaks of marrow suspension were then applied to appropriately labelled clean, dry microscopic slides.
d) The slides were allowed to air dry
e) The slides were then stained with polychrome methylene blue and eosin using a Ames Hema-Tek staining machine (Hema-Tek, Miles Laboratory Limited, Stoke Court, Stoke Pages, Slough, UK).
f) Slides were coded and scored blind.
g) 500 polychromatic erythrocytes were examined and the number containing micronuclei scored. The samples were also examined for evidence of cytotoxicity, which may be manifest in the ratio of different cell types in the bone marrow. - Evaluation criteria:
- 500 polychromatic erythrocytes were examined and the number containing micronuclei scored, for the test substance, control and positive control at the sampling times 24, 48 and 72 hrs. The samples were also examined for evidence of cytotoxicity, which may be manifest in the ratio of different cell types in the bone marrow. A statistically significant increase in polychromatic erythrocytes containing micronuclei is considered to be evidence of the clastogenic effect of the administered substance.
- Statistics:
- The results were analysed for significant difference from the control group using a one sided Student's 't' test.
Results and discussion
Test results
- Sex:
- male/female
- Genotoxicity:
- negative
- Toxicity:
- no effects
- Vehicle controls validity:
- valid
- Positive controls validity:
- valid
Any other information on results incl. tables
Table 1: Incidence of Micronuclei / 1000 Polychromatic Erythrocytes at Three Sampling Times
Group |
Compound |
Dose |
Incidence of micronuclei/1000 cells |
||
24 hours |
48 hours |
72 hours |
|||
1 |
Control (corn oil) |
10ml/kg |
5.3 |
5.0 |
4.6 |
2 |
Cyclophosphamide |
65mg/kg |
45.8** |
31.8** |
5.6 |
3 |
CTF |
600 mg/kg |
5.3 |
4.5 |
4.5 |
4 |
CTF |
375mg/kg |
4.0 |
2.6 |
2.4 |
** Statistically significant difference p<0.01 Student's 't' Test (one-sided)
CTF gave negative results at all three sampling times when compared with the control. The test system positive control (cyclophosphamide) gave an elevated and statistically significant increase in micronuclei at the 24 hour and 48 hour sampling times. But had fallen to control values at the 72 hour sampling time. This type of response is expected for cyclophosphamide, and shows specificity of the system, as cyclophosphamide is short lived and therefore has a transient effect.
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information): negative
CTF was not clastogenic in the mouse micronucleus test. - Executive summary:
CTF (2-chloro-5-trifluoromethylpyridine) is an intermediate in the manufacture of a herbicide.
CTF did not induce any statistically significant increase in the frequency of micronuclei when compared with control animals at any of the sampling times investigated.
Throughout the study the positive control substance cyclophosphamide showed the expected response.
These results indicate that CTF is not clastogenic in the mouse micronucleus test.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.